Drug Shortage Report for SANDOMIGRAN DS
Report ID | 19806 |
Drug Identification Number | 00511552 |
Brand name | SANDOMIGRAN DS |
Common or Proper name | Sandomigran |
Company Name | PALADIN PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PIZOTIFEN |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 tablets |
ATC code | N02CX |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-04-24 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-04-24 |
Shortage status | Resolved |
Updated date | 2019-04-25 |
Company comments | Avoided backorder |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-04-25 | English | Compare |
v4 | 2019-04-24 | French | Compare |
v3 | 2019-04-24 | English | Compare |
v2 | 2017-08-18 | French | Compare |
v1 | 2017-08-18 | English | Compare |
Showing 1 to 5 of 5